Open Access
EDITORIAL COMMENT
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases
Department of Genitourinary Medical Oncology
UT MD Anderson Cancer Center
Houston, Texas USA
Canadian Journal of Urology 2012, 19(3), 6268-6268.
Abstract
This article has no abstract.Cite This Article
APA Style
Tu, S., Chen, A.H. (2012). Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. Canadian Journal of Urology, 19(3), 6268–6268.
Vancouver Style
Tu S, Chen AH. Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. Can J Urology. 2012;19(3):6268–6268.
IEEE Style
S. Tu and A.H. Chen, “Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases,” Can. J. Urology, vol. 19, no. 3, pp. 6268–6268, 2012.

This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.